There have been 8 insider transactions during the 90-day period prior to the date of this filing from the activity of one insider all of which have been purchases and resulted in the acquisition of 1,200,000 company shares. This compares with the preceding 90-day window of time where there were 20 transactions from 2 insiders which resulted in the net acquisition of 1,355,000 shares.
This level of insider transactions is below that of the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 40.4 transactions per company, and disposition of 7,173 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119057372/xslF345X03/doc4.xml
|Sector Update: Chipmakers Carrying Tech Stocks to La...|
|Research Alert: CFRA Lifts View On Shares Of Transoc...|
|Citigroup Fined $4.5 Million for Failing to Supervis...|
|Sector Update: Financial Stocks Churning Higher as P...|
|Update: Perceptron Touches 15-Month High; Atlas Copc...|